LEONHARDT VENTURES NEWS
University Lab Partners @ UCI Cove Leonhardt Custom Bioelectric Inflammation Treatment Patent Issued by USPTO
Leonhardt Ventures LLC Announces Filing of Pioneering Patent Claims for Bioelectric Signaling-Based Brain Regeneration via Controlled Expressions of BDNF, GDF10, SDF1, IGF1, and Klotho
Mission Viejo, Calif, November 1, 2021 (PRDistribution) -- Leonhardt Ventures LLC today announced the filing of additional pioneering patent claims based on the discovery in their research labs of specific bioelectric signaling sequences able to control expressions...
Leonhardt Ventures LLC Announces Plans To Take Bids for MyoStim ED ErectiStim TM Erectile Dysfunction IP and Assets
ErectiStim TM United States, California, Newport Beach, June 02, 2021 (GLOBE NEWSWIRE) -- -- Leonhardt Ventures LLC and it's innovation accelerator subsidiary Leonhardt's Launchpads by Cal-X Stars Business Accelerator, Inc. today announced that they are actively...
Leonhardt Ventures LLC Issued Pioneering Patent for Bioelectric Inflammation Treatment Device and Method
Patent protects methods and devices for customized real time treatment of chronic inflammation related disorders with bioelectric stimulation based protein expressions and control Irvine, California —(PRDistribution)- Leonhardt Ventures LLC, a clinical stage...
Leonhardt’s Launchpads Mid-Year Financials Analysis and June 2021 Financials
June 2021 Cal-X Stars Business Accelerator, Inc. Financials Mid Year 2021 Leonhardt's...
2021 Letter to Stakeholders
2021 Letter to Stakeholders A highly FOCUSED organization on the brink of major contributions to healthcare Dear Stakeholders, It is truly an honor to serve as Executive Chairman and CEO of Leonhardt’s Launchpads by Cal-X Stars Business Accelerator, Inc. the...
Executive Office Review 2020 Full Year Financials
Cal-X Stars Business Accelerator, Inc. DBA Leonhardt's Launchpads Executive Office Review 2020 Full Year Financials Expenses Cash Wages = $153,645 - All members including CEO - Incredibly modest for company with over 600 patent claims and multiple products in clinical...
2021 LETTER TO STAKEHOLDERS
A highly FOCUSED organization on the brink of major contributions to healthcare Dear Stakeholders, It is truly an honor to serve as Executive Chairman and CEO of Leonhardt’s Launchpads by Cal-X Stars Business Accelerator, Inc. the innovation and startup accelerator...
Top Achievements by Each Development Team 2020
Heart & Cardiovascular Group https://leonhardtventures.com/heart-and-cardiovascular/ Second Heart Assist Long duration pre-clinical studies successful - Texas Heart Institute including video interview at THI. 109 hours plus in mock loop systems. 10 hour CRS...
Leonhardt’s Launchpads Executive Chairman & CEO Year End 2020 Stakeholder Update
Irvine, California, December 15th, 2020 – Leonhardt’s Launchpads by Cal-X Stars Business Accelerator, Inc. is an innovation accelerator HIGHLY FOCUSED on organ regeneration and recovery based on a common IP platform of bioelectrics and biologics –...